Founded 2018. £3,125m AUM across 3 programmes. 44 fund managers, 1,350 underlying portfolio companies. Portfolio: Wagestream (acq), Quantexa, Thought Machine (unicorns), Form3, Curve Therapeutics. 37-member team (9 Partners, 5 Principals). Crowded in £13.4bn from third parties. Government-owned subsidiary. 16% university spinouts, strong deeptech/life sciences focus.
Investment Focus
Investment Thesis
Fund of funds + direct co-investment. Growth stage (Series B-D primary). Life sciences (£150m+ committed), deep tech, fintech, AI, healthtech. £5m-£50m checks via core & Future Fund: Breakthrough (£425m R&D programme). UK-only, majority venture growth stage. Strong track record: 2 unicorns, 1 IPO, 3 exits. Avoids: early-stage lead investor role. Commercial basis with pari passu terms.
Interested in connecting?
Visit their website or reach out directly.